Product Code: GVR-4-68040-496-7
North America Acute Care Telemedicine Market Summary
The North America acute care telemedicine market size was estimated at USD 16.20 billion in 2025 and is projected to reach USD 45.35 billion by 2033, growing at a CAGR of 13.49% from 2026 to 2033. Factors such as the growing adoption of telemedicine solutions by healthcare providers, rising consumer demand and patient acceptance, delivery of enhanced quality of care, and the shortage of specialty physicians and healthcare staff contribute to market growth.
For instance, according to the Association of American Medical Colleges (AAMC), the U.S. is expected to witness a shortage of up to 86,000 physicians by 2036. The increasing demand for remote healthcare services is revolutionizing North America's acute care telemedicine industry. According to IntuitionLabs article published in January 2026, Remote patient monitoring (RPM) has become a vital component of acute and post-acute care by supporting continuous oversight of chronic and high-risk patients, improving clinical outcomes, and enabling early intervention. Nearly 50 million individuals in the U.S. currently use at least one RPM device to track health metrics, while approximately 80% of the population expresses a willingness to incorporate remote monitoring into routine medical care. Provider adoption has also accelerated rapidly, with 81% of clinicians using RPM in 2023, a 305% increase from 2021, emphasizing the growing integration of digital monitoring tools into acute care workflows.
Moreover, the increasing burden of chronic diseases and the need for rapid specialist access during medical emergencies have elevated the role of telemedicine platforms in acute care delivery. These solutions facilitate real-time physician consultations, remote diagnostics, and continuous patient surveillance, helping hospitals reduce emergency department congestion and improve clinical response times. The integration of advanced technologies such as artificial intelligence and Internet of Things enabled devices further strengthens acute care telemedicine by enabling predictive insights, seamless data exchange with hospital systems, and expanded access to critical care services in rural and underserved communities.
North America Acute Care Telemedicine Market Report Segmentation
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the North America acute care telemedicine market report based on delivery, application, end-use, and region:
- Delivery Outlook (Revenue, USD Million, 2021 - 2033)
- Clinician-to-Clinician
- Clinician-to-Patient
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Teleradiology
- Telepsychiatry
- Tele-ICU
- Teleneurology
- Telenephrology
- Others
- End-use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals and Clinics
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Delivery outlook
- 2.2.2. Application outlook
- 2.2.3. End Use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. North America Acute Care Telemedicine Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. North America Acute Care Telemedicine: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTLE Analysis
Chapter 4. North America Acute Care Telemedicine Market Segment Analysis, By Delivery, 2021 - 2033 (USD Million)
- 4.1. Definition and Scope
- 4.2. Delivery Market Share Analysis, 2025 & 2033
- 4.3. Segment Dashboard
- 4.4. Global North America Acute Care Telemedicine Market, by Delivery, 2021 to 2033
- 4.5. Clinician-to-Clinician
- 4.5.1. Clinician-to-Clinician Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Clinician-to-Patient
- 4.6.1. Clinician-to-Patient Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. North America Acute Care Telemedicine Market Segment Analysis, By Application, 2021 - 2033 (USD Million)
- 5.1. Definition and Scope
- 5.2. Application Market Share Analysis, 2025 & 2033
- 5.3. Segment Dashboard
- 5.4. Global North America Acute Care Telemedicine Market, by Application, 2021 to 2033
- 5.5. Teleradiology
- 5.5.1. Teleradiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Telepsychiatry
- 5.6.1. Telepsychiatry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Teleneurology
- 5.7.1. Teleneurology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.8. Tele-ICU
- 5.8.1. Tele-ICU Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.9. Telenephrology
- 5.9.1. Telenephrology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.10. Others
- 5.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. North America Acute Care Telemedicine Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)
- 6.1. Definition and Scope
- 6.2. End Use Market Share Analysis, 2025 & 2033
- 6.3. Segment Dashboard
- 6.4. Global North America Acute Care Telemedicine Market, by End Use, 2021 to 2033
- 6.5. Hospitals and Clinics
- 6.5.1. Hospitals and Clinics market estimates and forecasts, 2021 to 2033 (USD Million)
- 6.6. Others
- 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. North America Acute Care Telemedicine Market Segment Analysis, By Region, 2021- 2033 (USD Million)
- 7.1. Regional Market Share Analysis, 2025 & 2033
- 7.2. Regional Market Dashboard
- 7.3. Regional Market Snapshot
- 7.4. North America Acute Care Telemedicine Market Share by Region, 2025 & 2033:
- 7.5. North America
- 7.5.1. North America acute care telemedicine market, 2021 - 2033 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. U.S. acute care telemedicine market, 2021 - 2033 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Canada acute care telemedicine market, 2021 - 2033 (USD Million)
- 7.5.4. Mexico
- 7.5.4.1. Mexico acute care telemedicine market, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Profiles
- 8.3.1. Teladoc Health, Inc.
- 8.3.1.1. Company overview
- 8.3.1.2. Financial performance
- 8.3.1.3. Product benchmarking
- 8.3.1.4. Strategic initiatives
- 8.3.2. AMD Global Telemedicine
- 8.3.2.1. Company overview
- 8.3.2.2. Financial performance
- 8.3.2.3. Product benchmarking
- 8.3.2.4. Strategic initiatives
- 8.3.3. Eagle Telemedicine
- 8.3.3.1. Company overview
- 8.3.3.2. Financial performance
- 8.3.3.3. Product benchmarking
- 8.3.3.4. Strategic initiatives
- 8.3.4. AMN Healthcare Services Inc.
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Access TeleCare, LLC
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Enghouse Video (Vidyo, Inc.)
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. RelyMD
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Doctor On Demand (Included Health, Inc.)
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. GE HealthCare
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Advanced Telemed Services
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives